QQQ   438.54 (+0.75%)
AAPL   180.36 (-0.58%)
MSFT   410.03 (+0.57%)
META   489.25 (+1.08%)
GOOGL   137.36 (+0.72%)
AMZN   175.23 (+1.20%)
TSLA   200.19 (-0.92%)
NVDA   793.56 (+2.18%)
NIO   5.67 (+4.42%)
AMD   190.97 (+8.17%)
BABA   74.18 (-0.55%)
T   17.01 (+0.29%)
F   12.42 (+0.98%)
MU   90.22 (+0.57%)
CGC   3.27 (-2.68%)
GE   156.23 (+0.40%)
DIS   111.20 (+0.36%)
AMC   4.29 (-14.03%)
PFE   26.79 (-0.92%)
PYPL   60.29 (+0.07%)
XOM   104.66 (+0.33%)
QQQ   438.54 (+0.75%)
AAPL   180.36 (-0.58%)
MSFT   410.03 (+0.57%)
META   489.25 (+1.08%)
GOOGL   137.36 (+0.72%)
AMZN   175.23 (+1.20%)
TSLA   200.19 (-0.92%)
NVDA   793.56 (+2.18%)
NIO   5.67 (+4.42%)
AMD   190.97 (+8.17%)
BABA   74.18 (-0.55%)
T   17.01 (+0.29%)
F   12.42 (+0.98%)
MU   90.22 (+0.57%)
CGC   3.27 (-2.68%)
GE   156.23 (+0.40%)
DIS   111.20 (+0.36%)
AMC   4.29 (-14.03%)
PFE   26.79 (-0.92%)
PYPL   60.29 (+0.07%)
XOM   104.66 (+0.33%)
QQQ   438.54 (+0.75%)
AAPL   180.36 (-0.58%)
MSFT   410.03 (+0.57%)
META   489.25 (+1.08%)
GOOGL   137.36 (+0.72%)
AMZN   175.23 (+1.20%)
TSLA   200.19 (-0.92%)
NVDA   793.56 (+2.18%)
NIO   5.67 (+4.42%)
AMD   190.97 (+8.17%)
BABA   74.18 (-0.55%)
T   17.01 (+0.29%)
F   12.42 (+0.98%)
MU   90.22 (+0.57%)
CGC   3.27 (-2.68%)
GE   156.23 (+0.40%)
DIS   111.20 (+0.36%)
AMC   4.29 (-14.03%)
PFE   26.79 (-0.92%)
PYPL   60.29 (+0.07%)
XOM   104.66 (+0.33%)
QQQ   438.54 (+0.75%)
AAPL   180.36 (-0.58%)
MSFT   410.03 (+0.57%)
META   489.25 (+1.08%)
GOOGL   137.36 (+0.72%)
AMZN   175.23 (+1.20%)
TSLA   200.19 (-0.92%)
NVDA   793.56 (+2.18%)
NIO   5.67 (+4.42%)
AMD   190.97 (+8.17%)
BABA   74.18 (-0.55%)
T   17.01 (+0.29%)
F   12.42 (+0.98%)
MU   90.22 (+0.57%)
CGC   3.27 (-2.68%)
GE   156.23 (+0.40%)
DIS   111.20 (+0.36%)
AMC   4.29 (-14.03%)
PFE   26.79 (-0.92%)
PYPL   60.29 (+0.07%)
XOM   104.66 (+0.33%)

Intra-Cellular Therapies (ITCI) News Today

$69.48
-1.65 (-2.32%)
(As of 02:21 PM ET)
SourceHeadline
marketbeat.com logoEquities Analysts Issue Forecasts for Intra-Cellular Therapies, Inc.'s FY2024 Earnings (NASDAQ:ITCI)
marketbeat.com - February 29 at 8:41 AM
marketbeat.com logoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Stock Holdings Lifted by Trexquant Investment LP
marketbeat.com - February 29 at 7:53 AM
MarketBeat logoMichael Halstead Sells 7,907 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Stock
americanbankingnews.com - February 29 at 6:42 AM
MarketBeat logoSharon Mates Sells 22,590 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Stock
americanbankingnews.com - February 29 at 5:52 AM
MarketBeat logoLawrence J. Hineline Sells 13,337 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Stock
americanbankingnews.com - February 29 at 5:08 AM
MarketBeat logoJoel S. Marcus Sells 26,328 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Stock
americanbankingnews.com - February 29 at 4:32 AM
finance.yahoo.com logoEVP and General Counsel Michael Halstead Sells Shares of Intra-Cellular Therapies Inc
finance.yahoo.com - February 28 at 9:28 AM
globenewswire.com logoIntra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference
globenewswire.com - February 27 at 8:00 AM
markets.businessinsider.com logoOptimistic Buy Rating for Intra-Cellular Therapies Amid Growth and Operational Efficiency
markets.businessinsider.com - February 26 at 4:46 AM
MarketBeat logoIntra-Cellular Therapies, Inc. Expected to Post FY2025 Earnings of $1.30 Per Share (NASDAQ:ITCI)
americanbankingnews.com - February 26 at 3:32 AM
MarketBeat logoIntra-Cellular Therapies (NASDAQ:ITCI) Price Target Raised to $82.00 at Needham & Company LLC
americanbankingnews.com - February 25 at 6:06 AM
MarketBeat logoCanaccord Genuity Group Trims Intra-Cellular Therapies (NASDAQ:ITCI) Target Price to $100.00
americanbankingnews.com - February 25 at 5:32 AM
MarketBeat logoIntra-Cellular Therapies' (ITCI) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
americanbankingnews.com - February 25 at 4:58 AM
MarketBeat logoRoyal Bank of Canada Reiterates "Outperform" Rating for Intra-Cellular Therapies (NASDAQ:ITCI)
americanbankingnews.com - February 25 at 4:00 AM
finance.yahoo.com logoIntra-Cellular Therapies Full Year 2023 Earnings: EPS Beats Expectations
finance.yahoo.com - February 24 at 2:41 PM
marketbeat.com logoEagle Asset Management Inc. Has $21.52 Million Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
marketbeat.com - February 24 at 8:35 AM
MarketBeat logoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Given Consensus Rating of "Moderate Buy" by Analysts
americanbankingnews.com - February 24 at 1:52 AM
finance.yahoo.com logoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 23 at 5:04 PM
marketbeat.com logoIntra-Cellular Therapies (NASDAQ:ITCI) Releases Quarterly Earnings Results, Beats Expectations By $0.14 EPS
marketbeat.com - February 23 at 1:45 PM
marketbeat.com logoIntra-Cellular Therapies (NASDAQ:ITCI) Given Outperform Rating at Royal Bank of Canada
marketbeat.com - February 23 at 12:21 PM
marketbeat.com logoIntra-Cellular Therapies (NASDAQ:ITCI) Price Target Cut to $100.00 by Analysts at Canaccord Genuity Group
marketbeat.com - February 23 at 10:18 AM
marketbeat.com logoIntra-Cellular Therapies (NASDAQ:ITCI) Given New $82.00 Price Target at Needham & Company LLC
marketbeat.com - February 23 at 8:11 AM
marketbeat.com logoClearbridge Investments LLC Has $73.11 Million Stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
marketbeat.com - February 23 at 7:52 AM
finanznachrichten.de logoIntra-Cellular Therapies Inc.: Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update
finanznachrichten.de - February 22 at 4:01 PM
benzinga.com logoIntra-Cellular Therapies Stock (NASDAQ:ITCI), Short Interest Report
benzinga.com - February 22 at 4:01 PM
msn.com logoIntra-Cellular Therapies misses Q4 estimates
msn.com - February 22 at 10:37 AM
finance.yahoo.com logoIntra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update
finance.yahoo.com - February 22 at 10:37 AM
marketbeat.com logoHealthcare of Ontario Pension Plan Trust Fund Acquires 104,700 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
marketbeat.com - February 22 at 9:52 AM
gurufocus.com logoIntra-Cellular Therapies Inc (ITCI) Reports Robust Revenue Growth in 2023 Earnings
gurufocus.com - February 22 at 8:10 AM
globenewswire.com logoIntra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update
globenewswire.com - February 22 at 7:30 AM
investorplace.com logo3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition
investorplace.com - February 21 at 10:08 PM
msn.com logoIntra-Cellular Therapies Q4 2023 Earnings Preview
msn.com - February 21 at 12:35 PM
marketbeat.com logoFmr LLC Lowers Stock Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
marketbeat.com - February 20 at 7:30 AM
finance.yahoo.com logoFate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - February 19 at 2:57 PM
benzinga.com logoIntra-Cellular Therapies Stock (NASDAQ:ITCI) Dividends: History, Yield and Dates
benzinga.com - February 18 at 9:31 PM
wsj.com logoIntra-Cellular Therapies Inc.
wsj.com - February 18 at 4:30 PM
marketbeat.com logoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) is Silverarc Capital Management LLC's 8th Largest Position
marketbeat.com - February 18 at 12:53 PM
marketbeat.com logoMutual of America Capital Management LLC Has $2.73 Million Stock Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
marketbeat.com - February 17 at 7:13 AM
ca.finance.yahoo.com logoITCI Mar 2024 90.000 call
ca.finance.yahoo.com - February 17 at 6:42 AM
marketbeat.com logoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Short Interest Update
marketbeat.com - February 16 at 8:19 PM
marketbeat.com logoIntra-Cellular Therapies (NASDAQ:ITCI) PT Raised to $82.00
marketbeat.com - February 16 at 7:39 PM
marketbeat.com logoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Purchased by Charles Schwab Investment Management Inc.
marketbeat.com - February 16 at 5:24 AM
finance.yahoo.com logoUltragenyx (RARE) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - February 15 at 8:56 PM
finance.yahoo.com logoIntra-Cellular Therapies (ITCI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - February 15 at 3:56 PM
finance.yahoo.com logoITCI Apr 2024 65.000 put
finance.yahoo.com - February 15 at 10:55 AM
marketbeat.com logoPrime Capital Investment Advisors LLC Lowers Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
marketbeat.com - February 15 at 7:28 AM
finance.yahoo.com logoITCI Apr 2024 60.000 put
finance.yahoo.com - February 14 at 11:19 PM
marketbeat.com logoAtika Capital Management LLC Sells 7,000 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
marketbeat.com - February 14 at 4:31 PM
finance.yahoo.com logoBiotech Leader Intra-Cellular Therapies Nears Buy Point Ahead Of Earnings Report
finance.yahoo.com - February 13 at 10:04 AM
marketbeat.com logoBarclays PLC Has $3.32 Million Stock Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
marketbeat.com - February 13 at 4:23 AM
Get Intra-Cellular Therapies News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITCI and its competitors with MarketBeat's FREE daily newsletter.



ITCI Media Mentions By Week

ITCI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ITCI
News Sentiment

0.18

0.60

Average
Medical
News Sentiment

ITCI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ITCI Articles
This Week

40

4

ITCI Articles
Average Week

Get Intra-Cellular Therapies News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITCI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ITCI) was last updated on 2/29/2024 by MarketBeat.com Staff